Taiwan Hopax Chemicals Manufacturing Co (6509) Fair Value & Analysis
Basic Materials · TW · Market cap 9.1B TWD
Fair value as of: Jun 24, 2026
Analysis
Taiwan Hopax Chemicals Manufacturing Co (6509) currently trades at 48.45 TWD, while our model-based Fair Value estimate is 49.08 TWD — implying the stock looks roughly 1.3% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Taiwan Hopax Chemicals Manufacturing Co., Ltd. manufactures, processes, and sells chemical raw materials for pharmaceutical, industrial, paper making, and office stationery industries in Taiwan, rest of Asia, Europe, America, and internationally. It operates through Specialty Chemicals, Fine Chemicals, Office Stationery, and Other segments. The company offers paper making chemicals, such as hollow resins, dispersant, lubricants, anionic (cationic) surface sizing agent, ultra-fine dispersant for wet-grinding calcium carbonate, medium alkaline sizing agent, anion neutralizing agent, cohesion enhancer, retention and drainage aid, and titanium dioxide dispersant; and chemical materials for water treatment, including polymers, COD removal agent, fly ash curing agent, metal capturing agent, polyaluminum chloride, sedimentation control agent, geotechnical stabilizer, chelating agent, and dispersant. It also provides NCR chemicals comprising NTR, color developers, microcapsules, spacer, wal…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Taiwan Hopax Chemicals Manufacturing Co (6509) undervalued?
What is the fair value of 6509?
What is the quality score of 6509?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.